Cargando…

Me(2)SO perfusion time for whole-organ cryopreservation can be shortened: Results of micro-computed tomography monitoring during Me(2)SO perfusion of rat hearts

Cryopreservation of whole organs and specific tissues is an important and continually expanding field of medicine. The protocols currently used for organ preservation do not ensure survivability and functionality; the protocols for ovarian tissue lead to acceptable outcomes, but these are still capa...

Descripción completa

Detalles Bibliográficos
Autores principales: Bleisinger, Nathalie, Dittrich, Ralf, Strahl, Olga, Brauweiler, Robert, Hoffmann, Inge, Beckmann, Matthias W., Volk, Tilmann
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7467318/
https://www.ncbi.nlm.nih.gov/pubmed/32877442
http://dx.doi.org/10.1371/journal.pone.0238519
_version_ 1783577987108569088
author Bleisinger, Nathalie
Dittrich, Ralf
Strahl, Olga
Brauweiler, Robert
Hoffmann, Inge
Beckmann, Matthias W.
Volk, Tilmann
author_facet Bleisinger, Nathalie
Dittrich, Ralf
Strahl, Olga
Brauweiler, Robert
Hoffmann, Inge
Beckmann, Matthias W.
Volk, Tilmann
author_sort Bleisinger, Nathalie
collection PubMed
description Cryopreservation of whole organs and specific tissues is an important and continually expanding field of medicine. The protocols currently used for organ preservation do not ensure survivability and functionality; the protocols for ovarian tissue lead to acceptable outcomes, but these are still capable of further improvement. In general, cryopreservation protocols need to be optimized. One important approach to improving cryopreservation protocols in general involves reducing exposure to cytotoxic cryoprotective agents prior to freezing. This study, therefore, evaluated the real-time tissue penetration of dimethyl sulfoxide, a cryoprotective agent that is widely used in cryopreservation. Dimethyl sulfoxide penetration in rat hearts perfused with a 15% (v/v) dimethyl sulfoxide solution was examined in real-time using dynamic contrast-enhanced micro-computed tomography imaging. Viability of cardiomyocytes was not significantly affected by the dimethyl sulfoxide perfusion procedure. Two different perfusion rates were evaluated and compared with perfusion using a common iodine-based contrast agent (iomeprol). The dynamic contrast-enhanced micro-computed tomography imaging data showed that dimethyl sulfoxide flushes both the extracellular and intracellular spaces in rat heart tissue to 95% equilibration after ≈ 35 s via perfusion. Subsequent wash-out via perfusion is completed to 95% within ≈ 49 s. The equilibration duration routinely used in dimethyl sulfoxide–based protocols for cryopreservation should therefore be questioned. Shorter incubation duration would perhaps be sufficient, as well as being beneficial in relation to cell survivability. It would be helpful to have techniques for non-invasive real-time monitoring of the penetration of cryoprotective agents and such techniques should be used to revise cryopreservation protocols. Switching to perfusion-based equilibration procedures might be beneficial, if feasible.
format Online
Article
Text
id pubmed-7467318
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-74673182020-09-11 Me(2)SO perfusion time for whole-organ cryopreservation can be shortened: Results of micro-computed tomography monitoring during Me(2)SO perfusion of rat hearts Bleisinger, Nathalie Dittrich, Ralf Strahl, Olga Brauweiler, Robert Hoffmann, Inge Beckmann, Matthias W. Volk, Tilmann PLoS One Research Article Cryopreservation of whole organs and specific tissues is an important and continually expanding field of medicine. The protocols currently used for organ preservation do not ensure survivability and functionality; the protocols for ovarian tissue lead to acceptable outcomes, but these are still capable of further improvement. In general, cryopreservation protocols need to be optimized. One important approach to improving cryopreservation protocols in general involves reducing exposure to cytotoxic cryoprotective agents prior to freezing. This study, therefore, evaluated the real-time tissue penetration of dimethyl sulfoxide, a cryoprotective agent that is widely used in cryopreservation. Dimethyl sulfoxide penetration in rat hearts perfused with a 15% (v/v) dimethyl sulfoxide solution was examined in real-time using dynamic contrast-enhanced micro-computed tomography imaging. Viability of cardiomyocytes was not significantly affected by the dimethyl sulfoxide perfusion procedure. Two different perfusion rates were evaluated and compared with perfusion using a common iodine-based contrast agent (iomeprol). The dynamic contrast-enhanced micro-computed tomography imaging data showed that dimethyl sulfoxide flushes both the extracellular and intracellular spaces in rat heart tissue to 95% equilibration after ≈ 35 s via perfusion. Subsequent wash-out via perfusion is completed to 95% within ≈ 49 s. The equilibration duration routinely used in dimethyl sulfoxide–based protocols for cryopreservation should therefore be questioned. Shorter incubation duration would perhaps be sufficient, as well as being beneficial in relation to cell survivability. It would be helpful to have techniques for non-invasive real-time monitoring of the penetration of cryoprotective agents and such techniques should be used to revise cryopreservation protocols. Switching to perfusion-based equilibration procedures might be beneficial, if feasible. Public Library of Science 2020-09-02 /pmc/articles/PMC7467318/ /pubmed/32877442 http://dx.doi.org/10.1371/journal.pone.0238519 Text en © 2020 Bleisinger et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Bleisinger, Nathalie
Dittrich, Ralf
Strahl, Olga
Brauweiler, Robert
Hoffmann, Inge
Beckmann, Matthias W.
Volk, Tilmann
Me(2)SO perfusion time for whole-organ cryopreservation can be shortened: Results of micro-computed tomography monitoring during Me(2)SO perfusion of rat hearts
title Me(2)SO perfusion time for whole-organ cryopreservation can be shortened: Results of micro-computed tomography monitoring during Me(2)SO perfusion of rat hearts
title_full Me(2)SO perfusion time for whole-organ cryopreservation can be shortened: Results of micro-computed tomography monitoring during Me(2)SO perfusion of rat hearts
title_fullStr Me(2)SO perfusion time for whole-organ cryopreservation can be shortened: Results of micro-computed tomography monitoring during Me(2)SO perfusion of rat hearts
title_full_unstemmed Me(2)SO perfusion time for whole-organ cryopreservation can be shortened: Results of micro-computed tomography monitoring during Me(2)SO perfusion of rat hearts
title_short Me(2)SO perfusion time for whole-organ cryopreservation can be shortened: Results of micro-computed tomography monitoring during Me(2)SO perfusion of rat hearts
title_sort me(2)so perfusion time for whole-organ cryopreservation can be shortened: results of micro-computed tomography monitoring during me(2)so perfusion of rat hearts
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7467318/
https://www.ncbi.nlm.nih.gov/pubmed/32877442
http://dx.doi.org/10.1371/journal.pone.0238519
work_keys_str_mv AT bleisingernathalie me2soperfusiontimeforwholeorgancryopreservationcanbeshortenedresultsofmicrocomputedtomographymonitoringduringme2soperfusionofrathearts
AT dittrichralf me2soperfusiontimeforwholeorgancryopreservationcanbeshortenedresultsofmicrocomputedtomographymonitoringduringme2soperfusionofrathearts
AT strahlolga me2soperfusiontimeforwholeorgancryopreservationcanbeshortenedresultsofmicrocomputedtomographymonitoringduringme2soperfusionofrathearts
AT brauweilerrobert me2soperfusiontimeforwholeorgancryopreservationcanbeshortenedresultsofmicrocomputedtomographymonitoringduringme2soperfusionofrathearts
AT hoffmanninge me2soperfusiontimeforwholeorgancryopreservationcanbeshortenedresultsofmicrocomputedtomographymonitoringduringme2soperfusionofrathearts
AT beckmannmatthiasw me2soperfusiontimeforwholeorgancryopreservationcanbeshortenedresultsofmicrocomputedtomographymonitoringduringme2soperfusionofrathearts
AT volktilmann me2soperfusiontimeforwholeorgancryopreservationcanbeshortenedresultsofmicrocomputedtomographymonitoringduringme2soperfusionofrathearts